Home - Products - Tyrosine Kinase - FLT3 - CGS 27023A

CGS 27023A

CAS No. 161314-82-5

CGS 27023A ( CGS-27023A; CGS 27023A; MMI270B )

Catalog No. M17341 CAS No. 161314-82-5

CGS 27023A is a non-peptidic, potent, and orally active stromelysin inhibitor.

Purity : 98%

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	52	In Stock
5MG	77	In Stock
10MG	107	In Stock
25MG	261	In Stock
50MG	379	In Stock
100MG	Get Quote	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

CGS 27023A
Note

Research use only, not for human use.
Brief Description

CGS 27023A is a non-peptidic, potent, and orally active stromelysin inhibitor.
Description

CGS-27023A is a novel matrix metalloproteinase inhibitor.
Synonyms

CGS-27023A; CGS 27023A; MMI270B
Pathway

Tyrosine Kinase
Target

FLT3
Recptor

MMP
Research Area

——
Indication

——

Chemical Information

CAS Number

161314-82-5
Formula Weight

429.92
Molecular Formula

C18H24ClN3O5S
Purity

98%
Solubility

——
SMILES

C(=O)([C@@H](C(C)C)N(Cc1cnccc1)S(=O)(=O)c1ccc(cc1)OC)NO.Cl
Chemical Name

(2R)-N-hydroxy-2-[(4-methoxyphenyl)sulfonyl-(pyridin-3-ylmethyl)amino]-3-methylbutanamide

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. MacPherson LJ, et al. J Med Chem. 1997 Aug 1;40(16):2525-32.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

KIN1148

KIN1148 is a novel small-molecule adjuvant that acts through the RIG-I pathway and IRF-3 transcription factor to stimulate inN/Ate immunity and protection following viral infection.
Crenolanib

Crenolanib (CP-868596) is a potent, selective PDGFR/Flt-3 inhibitor.
Gilteritinib

A potent FLT3/AXL inhibitor with IC50 of 0.73 nM/0.29 nM respectively.

Sign In Join Free